Lithium is a ‘gold standard’ drug for treating bipolar disorder, however not everyone responds in the same way. New research published in BioMed Central’s open access journal Biology of Mood & Anxiety Disorders finds that this is true at the levels of gene activation, especially in the activation or repression of genes which alter the level the apoptosis (programmed cell death).
The same gene variations that make it difficult to stop smoking also increase the likelihood that heavy smokers will respond to nicotine-replacement therapy and drugs that thwart cravings, a new study shows.
Antidepressive drugs reduce the mortality rate of schizophrenic patients, while treatment with bensodiazepines greatly increases it, especially as regards suicide. Giving several antipsychotics simultaneously, however, seems to have no effect at all. This according to a new study examining different drug combinations administered to patients with schizophrenia.
A new editorial released this week offers clarity and structure on confusing drug and alcohol addiction terminology for prescribers, users and regulators. “Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?” is published in the Journal of Psychopharmacology, the official journal of the British Association for Psychopharmacology, published by SAGE.
A new study published in the journal Molecular Psychiatry has identified that some antipsychotic drugs can have adverse side effects such as diabetes and obesity as they activate the TGFbeta pathway, a mechanism known to control cellular functions such as insulin production.
New research released this week by the University of Buffalo suggests smokers might have more success at kicking the habit if they start using smoking cessation medications, such as varenicline, for several weeks prior to their quit date. Findings showed that smokers who took the medication for four weeks prior to quitting were more likely to remain tobacco-free three months after the trail ended, compared to those who only took the drug for the regularly prescribed time frame of one week. The female participants also fared better in their quest to quit, with 67% remaining smoke free at the three month follow up.
New research presented in the Journal of Psychological Medicine has suggested that people suffering from mood or anxiety disorders could be more likely to abuse opioids.
It is widely regarded that doctor’s don’t have the best hand writing. Illegible hand writing can result in serious problems when pharmacists attempt to read a prescription and fill an order correctly. This can, and has, lead to a number of problems in providing patients with the correct medication and dosage for their conditions.
New research from John Hopkins has suggested that an electronic prescription drug ordering system, coupled with a computerized method of detailing adverse reactions can help to significantly reduce the number of medication errors within psychiatric units. The system can help psychiatric staff to effectively keep track of not only psychotropic medications and effects, but also track and analyse the effects of other essential drug therapies in combination.
The Tufts CTSI has today released a multi-state study on psychotropic medication oversight in foster care. The research notes a majority of states reviewed within the study reported an increase of minors within the foster care system taking psychotropic medications.
New research details, for the first time, the sequence of reactions caused by popular SSRI antidepressant, Prozac, at a neuronal level.